| abstract |
"pharmaceutical product comprising a muscarinic receptor antagonist and a second active ingredient." The present invention relates to a pharmaceutical product, kit or composition comprising a first active ingredient that is a selected muscarinic receptor antagonist, and a second active ingredient that is selected from a phosphodiesterase inhibitor, a receptor modulator of chemokine, a kinase function inhibitor, a protease inhibitor, a steroidal glucocorticoid receptor agonist, a non-steroidal glucocorticoid receptor agonist and a purinoceptor antagonist, for use in the treatment of respiratory diseases such as chronic obstructive pulmonary disease and asthma. |